Recent Press Releases

Genoa Pharmaceuticals Receives Orphan-Drug Designation for Pirfenidone in the Inhaled Treatment of Idiopathic Pulmonary Fibrosis (IPF)

SAN DIEGO, Aug. 5, 2014 /PRNewswire/ -- Genoa Pharmaceuticals, the leader in inhaled medicines for pulmonary fibrosis, today announced the U.S. Food and Drug Administration (FDA) has granted...

Fresenius Kabi Receives FDA approval for Kabiven and Perikabiven

First and only three-chamber bag available in the United States for parenteral nutrition LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has received approval from the U.S....

AB SCIEX and Dalton Pharma Services Collaborate to Advance Antibody-Drug Conjugate Analysis

TORONTO--()--AB SCIEX and Dalton Pharma Services (Dalton) announced today a research collaboration to develop Antibody-Drug Conjugate (ADC) analysis capabilities. This will include...

Cenix BioScience and Metanomics Health Sign Research Agreement

Cenix BioScience GmbH, a leading preclinical contract research provider and technology developer specialized in genome-scale gene modulation studies and high throughput, high content pharmacology,...

Louisiana Tech researchers use 3D printers to create custom medical implants

Breakthrough technology creates materials infused with cancer-fighting drugs, antibiotics August 20, 2014 A team of researchers at Louisiana Tech University has developed an innovative method for...

EastGate Acquisitions Augments Its Sub-Micron Self-Nanoemulsifying Platform Technology

SALT LAKE CITY and TORONTO, Aug. 18 , 2014 /PRNewswire/ -- EastGate Acquisitions Corporation (OTCBB: ESAQ), an emerging pharmaceutical company exploring drug delivery innovations in the development...

Depomed Prevails in Gralise® ANDA Litigation Blocking Generic Entry Until 2024

NEWARK, Calif., Aug. 19, 2014 /PRNewswire/ -- Depomed, Inc. (Nasdaq: DEPO) today announced Judge Joel A. Pisano of the U.S. District Court for the District of New Jersey has ruled in favor of Depomed...

Stimuli-Responsive Drug Delivery System Prevents Transplant Rejection, Reduces Toxicity, and Lasts for Months

Press Release - Aug 13, 2014 Boston, MA - Following a tissue graft transplant-such as that of the face, hand, arm or leg-it is standard for doctors to immediately give transplant recipients...

FDA Advisory Committee Recommends Approval of Tiotropium Respimat for the Maintenance Treatment of COPD

Published: Aug 14, 2014 4:35 p.m. ET Committee Voted Based on Clinical Data from Eight Efficacy Trials RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc....

Arrowhead Reports Fiscal 2014 Third Quarter Financial Results and Provides Update on ARC-520

August 12, 2014 04:01 PM Eastern Daylight Time PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics,...

BioDelivery Sciences Announces BEMA Buprenorphine NDA Submission on Track following Pre-NDA Meeting with FDA

BEMA Buprenorphine on track for late 2014 or early 2015 NDA filing by partner Endo Pharmaceuticals RALEIGH, N.C., Aug. 12, 2014-- BioDelivery Sciences International, Inc. BDSI -1.51% announced that...

BioDelivery Sciences Provides Update on Ongoing Phase 3 Pivotal Trial for Clonidine Topical Gel for Painful Diabetic Neuropathy

Aug 06, 2014 07:00 ET RALEIGH, N.C., Aug. 6, 2014 /PRNewswire/ -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI) announced today that it has completed a pre-specified interim analysis of the...

BD AutoShield™ Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes

BD AutoShield™ Duo Pen Needle Now Available through Retail Pharmacies for People with Diabetes FRANKLIN LAKES, N.J., Aug. 6, 2014 /PRNewswire/ -- BD Medical, a segment of BD (Becton, Dickinson...

biOasis Releases Quantitative Results: siRNA-Transcendpep Reduces Target Gene Expression in the Brain

biOasis Releases Quantitative Results: siRNA-Transcendpep Reduces Target Gene Expression in the Brain The Ability to Deliver siRNAs to the Brain Represents a Major Advancement in the Potential...

Surprise discovery could see graphene used to improve health

A chance discovery about the 'wonder material' graphene – already exciting scientists because of its potential uses in electronics, energy storage and energy generation – takes it...

FAMU Researchers Awarded 100K National Science Foundation Grant

Tallahassee, Florida (PRWEB) July 29, 2014 Florida Agricultural and Mechanical University (FAMU) has been awarded a $100,000 grant by the National Science Foundation (NSF) Division of Materials...

MTTI and National Health Research Institutes Have Joined Forces in Developing Novel Cancer Therapeutics

WEST CHESTER, Pa.--()--Molecular Targeting Technologies, Inc. (MTTI) and National Health Research Institutes (NHRI), Taiwan announced today that the two parties have formed a joint...

Mystic Pharmaceuticals Receives Notice of Allowance for Novel Powder Drug Delivery Technology

AUSTIN, Texas--()--Mystic Pharmaceuticals, Inc., a privately held, integrated specialty pharmaceutical company, announced today it has received a Notice of Allowance from the United...

Carnegie Mellon Chemists Create Nanofibers Using Unprecedented New Method

PITTSBURGH—Researchers from Carnegie Mellon University have developed a novel method for creating self-assembled protein/polymer nanostructures that are reminiscent of fibers found in living...

STENTYS Reallocates Resources to Focus on its Advanced Drug-Eluting Stent Program

PRINCETON, N.J. and PARIS – July 31, 2014 – STENTYS (FR0010949404 — STNT), a medical technology company commercializing in Europe the world's first and only Self-Apposing®...